Skip to main contentAll experts

DrRobert Mckenna

PRG DIR & DIS PROF

MD-BIOCHEM - MOLECULAR BIOL

Orcid identifier0000-0002-2792-935X (opens in a new tab)⁠
  • PRG DIR & DIS PROF
    MD-BIOCHEM - MOLECULAR BIOL

GRANTS

  • GRANT
    Structural and Biophysical Characterization of AAV Genome Packaging and Ejection for Enhanced Vector Design
    National Institute of Health Niaid14 Jul 2026 - 30 Jun 2028
    Active
  • GRANT
    Structural and Mechanistic Understanding of Antibody Inhibition of AAV2 Gene Therapy
    National Institute of Health Niaid4 May 2026 - 15 May 2028
    Active
  • GRANT
    Design of immunogenic recombinant AAVs for breast cancer immunotherapy
    Florida Breast Cancer Foundation8 Jul 2025 - 30 Jun 2027
    Active
  • GRANT
    Engineering AAV for safe and efficient gene delivery to the human retina
    National Institute of Health Nei5 Sep 2024 - 30 Jun 2029
    Active
  • GRANT
    Leaving no child behind: enabling universal access to AAV gene therapies by vector bio-engineering to evade pre-existing natural immunity
    National Health and Med Research Council9 Jul 2024 - 31 Dec 2027
    Active
  • GRANT
    AAV capsids and their cellular interactions
    National Institute of Health Nigms22 Apr 2024 - 31 Jan 2028
    Active
  • GRANT
    Structural characterization of AAV capsid ligand complexes
    Avitide3 Apr 2024 - 12 Apr 2024
    Expired
  • GRANT
    A modified arrestin1 to enhance glycolysis in photoreceptors as a therapeutic approach to slowing retinal degeneration
    National Institute of Health Nei8 Dec 2023 - 31 Dec 2028
    Active
  • GRANT
    Structural characterization of AAV capsid ligand complexes
    Avitide14 Nov 2023 - 18 Jan 2024
    Expired
  • GRANT
    A study into the expression of TTV and its possible development as a gene therapy vector#######
    Intima Bioscience6 Oct 2022 - 30 Oct 2023
    Expired
  • GRANT
    RNA virus capture of host chemokines: Understanding novel viral mechanisms of immune manipulation
    National Institute of Health Niaid14 Jan 2022 - 31 Dec 2025
    Expired
  • GRANT
    Cryo-EM analysis of AAV capsid full/empty ratio determinations
    Stridebio3 Jan 2022 - 31 Jul 2022
    Expired
  • GRANT
    Generation of AAV1 VP3-only DNA empty capsids
    Thermo Finnigan9 Dec 2021 - 14 Jan 2022
    Expired
  • GRANT
    Generation of AAV1 VP3 only DNA empty capsids
    Thermo Finnigan20 Jul 2021 - 1 Oct 2021
    Expired
  • GRANT
    Adverum Task Order #2 - Structure determination of AAV variants and 3D homology model building
    Adverum Biotechnologies Inc7 Jun 2020 - 30 May 2022
    Expired
  • GRANT
    Correlative structure and function studies of adeno-associated virus particles during viral genome release
    National Institute of Health Niaid7 Apr 2020 - 31 Mar 2023
    Expired
  • GRANT
    Asparagine Synthetase Deficiency
    26 Feb 2020 - 28 Feb 2023
    Expired
  • GRANT
    AAV capsids and their cellular interactions
    National Institute of Health Nigms22 Nov 2019 - 30 Apr 2024
    Expired
  • GRANT
    Anti-viral Mechanisms of Defensins
    National Institute of Health Niaid26 Jun 2019 - 30 Apr 2025
    Expired
  • GRANT
    A role for AAV Rep in genome packaging efficiency
    Intima Bioscience5 Jun 2018 - 30 Apr 2022
    Expired
  • GRANT
    Characterization of Poliovirus VLPs Using a Mammalian Cell-Free System
    World Health Organization10 May 2018 - 31 Dec 2018
    Expired
  • GRANT
    Targeted Gene Therapy of Heart Failure Post Myocardial Infarction
    National Institute of Health Nhlbi10 May 2018 - 31 Mar 2023
    Expired
  • GRANT
    Characterization of Poliovirus VLPs Using a Mammalian Cell-Free System
    World Health Organization14 Mar 2017 - 31 Dec 2017
    Expired
  • GRANT
    AAV1 Variants for CNS Targeted Therapies
    Voyager Therapeutics Inc15 Dec 2016 - 9 May 2022
    Expired
  • GRANT
    Collaborative Research: Geometric Elucidation of Supramolecular Assembly and Allostery, with Experimental Validation
    National Science Foundation29 Aug 2016 - 31 Aug 2023
    Expired